Stay updated on Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Sign up to get notified when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    0.3%
    Check dated 2025-08-24T08:17:41.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.4%
    Check dated 2025-08-17T04:55:54.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.0%
    Check dated 2025-08-10T00:44:49.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.5%
    Check dated 2025-08-01T19:02:26.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.4%
    Check dated 2025-07-25T14:05:04.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.5 to version 2.16.6.
    Difference
    0.4%
    Check dated 2025-07-18T10:59:20.000Z thumbnail image

Stay in the know with updates to Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.